Posted in Uncategorized Novavax Investor Relations – SEC filings November 20, 2022 Novavax, Inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Latest investor presentation Latest clinical presentation https://ir.novavax.com/sec-filings